Jonathan Harrison Griffin - 08 Feb 2024 Form 4 Insider Report for BALCHEM CORP (BCPC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
12 Feb 2024, 18:42:47 UTC
Prior SEC filing
15 Feb 2023
Next SEC filing
13 Feb 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Travis Larsen, Attorney in Fact for Jonathan Harrison Griffin

Key filing fact

Jonathan Harrison Griffin filed Form 4 for BALCHEM CORP (BCPC) on 12 Feb 2024.

Key facts

  • This page summarizes Jonathan Harrison Griffin's Form 4 filing for BALCHEM CORP (BCPC).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 12 Feb 2024, 18:42.

Change

  • Previous filing in this sequence was filed on 15 Feb 2023.
  • Current net transaction value: -$113,740.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BCPC transaction

Common Stock

Award

Transaction value
$0
Shares
+720
Change %
+6.8%
Price
$0.000000
Shares after
11,360
Date
08 Feb 2024
Ownership
Direct
Footnotes
F1, F2
BCPC transaction

Common Stock

Award

Transaction value
$0
Shares
+2,390
Change %
+21%
Price
$0.000000
Shares after
13,750
Date
08 Feb 2024
Ownership
Direct
Footnotes
F3
BCPC transaction

Common Stock

Tax liability

Transaction value
$113,740
Shares
-793
Change %
-5.8%
Price
$143.43
Shares after
12,957
Date
08 Feb 2024
Ownership
Direct
Footnotes
F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BCPC transaction Derivative

Stock Option

Award

Transaction value
$0
Shares
+2,400
Change %
Price
$0.000000
Shares after
2,400
Date
08 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,400
Exercise price
$143.43
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.

Footnote F2

Includes acquisition of shares under the Balchem Corporation 401(k) plan.

Footnote F3

Represents the vesting of performance stock units (includes 36 dividend equivalent shares) for the 2021-2023 performance period.

Footnote F4

793 of the 2,390 performance stock units that vested on February 8, 2024 were withheld to cover tax requirement due upon vesting.

Footnote F5

Options vest 20% Year 1; 40% Year 2: and 40% Year 3.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .